BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kalapesi, F B
Right arrow Articles by Hill, M A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kalapesi, F B
Right arrow Articles by Hill, M A
British Journal of Ophthalmology 2005;89:758-763
© 2005 BMJ Publishing Group Ltd


EXTENDED REPORT

Human ganglion cells express the alpha-2 adrenergic receptor: relevance to neuroprotection

F B Kalapesi1, M T Coroneo2, M A Hill1

1 Cell Biology Laboratory, Department of Anatomy, School of Medical Sciences, University of New South Wales, Sydney 2052, Australia
2 Department of Ophthalmology, Prince of Wales Hospital, University of New South Wales, Sydney 2052, Australia

Correspondence to:
Correspondence to:
Dr Mark Hill
Department of Anatomy, University of New South Wales, Sydney NSW 2052, Australia; m.hill{at}unsw.edu.au

Background/aim: Alpha-2{alpha} adrenergic receptor ({alpha}2-AR) agonists are thought to be neuroprotective, preventing retinal ganglion cell death independent of pressure reduction. Previous studies have identified {alpha}2-ARs in rat retina. The authors aimed to demonstrate the presence and localisation of {alpha}2-ARs in human and rat retina and on the rat retinal ganglion cell line, RGC-5.

Methods: Seven postmortem human and three postmortem rat eyes were paraformaldehyde fixed and frozen. RGC-5 cells were also paraformaldehyde fixed. The expression of {alpha}2A-ARs was determined by antibody immunofluorescence.

Results: {alpha}2A-AR expression was identified in the human retina, on ganglion cells, and cells in the inner and outer nuclear layers (INL, ONL). Differential {alpha}2A-AR staining patterns in the INL and ONL suggest a further restriction to as yet unidentified neuronal subclasses. The RGC-5 cell line also expressed {alpha}2A-ARs in undifferentiated cells and an increased expression upon fully differentiated cells.

Conclusion: {alpha}2-AR agonists in addition to their pressure lowering effects in the eye, may act directly upon retinal neurons, including retinal ganglion cells. The presence of {alpha}2-ARs on the RGC-5 cell line allows future investigation of these possible direct effects using in vitro glaucoma model systems.


Abbreviations: {alpha}2-AR, alpha-2 adrenergic receptor; CRALBP, cellular retinaldehyde binding protein; GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; PBS, phosphate buffered saline

Keywords: human ganglion cells; alpha-2 receptors




This article has been cited by other articles:


Home page
IOVSHome page
C.-J. Dong, Y. Guo, P. Agey, L. Wheeler, and W. A. Hare
{alpha}2 Adrenergic Modulation of NMDA Receptor Function as a Major Mechanism of RGC Protection in Experimental Glaucoma and Retinal Excitotoxicity
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4515 - 4522.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C.-J. Dong, Y. Guo, L. Wheeler, and W. A. Hare
{alpha}2 Adrenergic Receptor-Mediated Modulation of Cytosolic Ca++ Signals at the Inner Plexiform Layer of the Rat Retina
Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1410 - 1415.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd.